Targeted Therapy for Advanced or Metastatic Differentiated Thyroid Carcinoma

被引：0
作者：
Wirth, Lori J.
机构：
来源：
CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY | 2015年 / 13卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：9 / 16
页数：8
相关论文
共 23 条
  • [1] Integrated Genomic Characterization of Papillary Thyroid Carcinoma
    Agrawal, Nishant
    Akbani, Rehan
    Aksoy, B. Arman
    Ally, Adrian
    Arachchi, Harindra
    Asa, Sylvia L.
    Auman, J. Todd
    Balasundaram, Miruna
    Balu, Saianand
    Baylin, Stephen B.
    Behera, Madhusmita
    Bernard, Brady
    Beroukhim, Rameen
    Bishop, Justin A.
    Black, Aaron D.
    Bodenheimer, Tom
    Boice, Lori
    Bootwalla, Moiz S.
    Bowen, Jay
    Bowlby, Reanne
    Bristow, Christopher A.
    Brookens, Robin
    Brooks, Denise
    Bryant, Robert
    Buda, Elizabeth
    Butterfield, Yaron S. N.
    Carling, Tobias
    Carlsen, Rebecca
    Carter, Scott L.
    Carty, Sally E.
    Chan, Timothy A.
    Chen, Amy Y.
    Cherniack, Andrew D.
    Cheung, Dorothy
    Chin, Lynda
    Cho, Juok
    Chu, Andy
    Chuah, Eric
    Cibulskis, Kristian
    Ciriello, Giovanni
    Clarke, Amanda
    Clayman, Gary L.
    Cope, Leslie
    Copland, John A.
    Covington, Kyle
    Danilova, Ludmila
    Davidsen, Tanja
    Demchok, John A.
    DiCara, Daniel
    Dhalla, Noreen
    [J]. CELL, 2014, 159 (03) : 676 - 690
  • [2] [Anonymous], 2014, THYR CARC
  • [3] Efficacy of pazopanib in progressive, radioiodine-refractory, metastatic differentiated thyroid cancers: results of a phase 2 consortium study
    Bible, Keith C.
    Suman, Vera J.
    Molina, Julian R.
    Smallridge, Robert C.
    Maples, William J.
    Menefee, Michael E.
    Rubin, Joseph
    Sideras, Kostandinos
    Morris, John C., III
    McIver, Bryan
    Burton, Jill K.
    Webster, Kevin P.
    Bieber, Carolyn
    Traynor, Anne M.
    Flynn, Patrick J.
    Goh, Boon Cher
    Tang, Hui
    Ivy, Susan Percy
    Erlichman, Charles
    [J]. LANCET ONCOLOGY, 2010, 11 (10) : 962 - 972
  • [4] Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial
    Brose, Marcia S.
    Nutting, Christopher M.
    Jarzab, Barbara
    Elisei, Rossella
    Siena, Salvatore
    Bastholt, Lars
    de la Fouchardiere, Christelle
    Pacini, Furio
    Paschke, Ralf
    Shong, Young Kee
    Sherman, Steven I.
    Smit, Johannes W. A.
    Chung, John
    Kappeler, Christian
    Pena, Carol
    Molnar, Istvan
    Schlumberger, Martin J.
    [J]. LANCET, 2014, 384 (9940) : 319 - 328
  • [5] Small-molecule MAPK inhibitors restore radioiodine incorporation in mouse thyroid cancers with conditional BRAF activation
    Chakravarty, Debyani
    Santos, Elmer
    Ryder, Mabel
    Knauf, Jeffrey A.
    Liao, Xiao-Hui
    West, Brian L.
    Bollag, Gideon
    Kolesnick, Richard
    Thin, Tin Htwe
    Rosen, Neal
    Zanzonico, Pat
    Larson, Steven M.
    Refetoff, Samuel
    Ghossein, Ronald
    Fagin, James A.
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2011, 121 (12) : 4700 - 4711
  • [6] Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
    Cooper, David S.
    Doherty, Gerard M.
    Haugen, Bryan R.
    Kloos, Richard T.
    Lee, Stephanie L.
    Mandel, Susan J.
    Mazzaferri, Ernest L.
    McIver, Bryan
    Pacini, Furio
    Schlumberger, Martin
    Sherman, Steven I.
    Steward, David L.
    Tuttle, R. Michael
    [J]. THYROID, 2009, 19 (11) : 1167 - 1214
  • [7] Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: Benefits and limits of radioiodine therapy
    Durante, C.
    Haddy, N.
    Baudin, E.
    Leboulleux, S.
    Hartl, D.
    Travagli, J. P.
    Caillou, B.
    Ricard, M.
    Lumbroso, J. D.
    De Vathaire, F.
    Schlumberger, M.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (08) : 2892 - 2899
  • [8] BRAFV600E mutation and outcome of patients with papillary thyroid carcinoma:: A 15-year median follow-up study
    Elisei, Rossella
    Ugolini, Clara
    Viola, David
    Lupi, Cristiana
    Biagini, Agnese
    Giannini, Riccardo
    Romei, Cristina
    Miccoli, Paolo
    Pinchera, Aldo
    Basolo, Fulvio
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2008, 93 (10) : 3943 - 3949
  • [9] Selumetinib-Enhanced Radioiodine Uptake in Advanced Thyroid Cancer
    Ho, Alan L.
    Grewal, Ravinder K.
    Leboeuf, Rebecca
    Sherman, Eric J.
    Pfister, David G.
    Deandreis, Desiree
    Pentlow, Keith S.
    Zanzonico, Pat B.
    Haque, Sofia
    Gavane, Somali
    Ghossein, Ronald A.
    Ricarte-Filho, Julio C.
    Dominguez, Jose M.
    Shen, Ronglai
    Tuttle, R. Michael
    Larson, Steve M.
    Fagin, James A.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (07) : 623 - 632
  • [10] Vandetanib in locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 2 trial
    Leboulleux, Sophie
    Bastholt, Lars
    Krause, Thomas
    de la Fouchardiere, Christelle
    Tennvall, Jan
    Awada, Ahmad
    Manuel Gomez, Jose
    Bonichon, Francoise
    Leenhardt, Laurence
    Soufflet, Christine
    Licour, Muriel
    Schlumberger, Martin J.
    [J]. LANCET ONCOLOGY, 2012, 13 (09) : 897 - 905
123